
Sumitomo Pharma Co., Ltd. — Investor Relations & Filings
Sumitomo Pharma Co., Ltd. is a research and development-driven pharmaceutical company focused on creating innovative pharmaceuticals and healthcare solutions. The company's primary therapeutic areas are Psychiatry & Neurology and Oncology, with additional activities in diabetes, rare diseases, and women's health. A key aspect of its R&D strategy is the integration of established expertise in small molecule drug discovery with pioneering modalities such as regenerative medicine and cell therapy. The company's mission is to translate scientific innovation into real-world solutions to contribute to the betterment of healthcare and fuller lives for people worldwide, with a strategic business focus on Japan and the United States.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第三者割当増資の結果(不実施)に関するお知らせ | 2026-05-22 | Japanese | |
| 訂正有価証券届出書(参照方式) | 2026-05-13 | Japanese | |
| 訂正有価証券届出書(参照方式) | 2026-04-27 | Japanese | |
| 訂正臨時報告書 | 2026-04-27 | Japanese | |
| 発行価格および売出価格等の決定に関するお知らせ | 2026-04-20 | Japanese | |
| 訂正発行登録書 | 2026-04-20 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 46782810 | 第三者割当増資の結果(不実施)に関するお知らせ | 2026-05-22 | Japanese | ||
| 45444669 | 訂正有価証券届出書(参照方式) | 2026-05-13 | Japanese | ||
| 37236520 | 訂正有価証券届出書(参照方式) | 2026-04-27 | Japanese | ||
| 37236463 | 訂正臨時報告書 | 2026-04-27 | Japanese | ||
| 46877809 | 発行価格および売出価格等の決定に関するお知らせ | 2026-04-20 | Japanese | ||
| 34689549 | 訂正発行登録書 | 2026-04-20 | Japanese | ||
| 34689544 | 訂正有価証券届出書(参照方式) | 2026-04-20 | Japanese | ||
| 34689540 | 訂正臨時報告書 | 2026-04-20 | Japanese | ||
| 34689537 | 発行登録追補書類(株券、社債券等) | 2026-04-20 | Japanese | ||
| 33791870 | 有価証券届出書(参照方式) | 2026-04-08 | Japanese | ||
| 33791843 | 訂正発行登録書 | 2026-04-08 | Japanese | ||
| 33791777 | 臨時報告書 | 2026-04-08 | Japanese | ||
| 33037826 | 訂正発行登録書 | 2026-03-25 | Japanese | ||
| 32859262 | 発行登録書(株券、社債券等) | 2026-03-02 | Japanese | ||
|
2025
1 filing
| |||||
| 8070292 | 確認書 | 2025-11-04 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Sumitomo Pharma Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11358/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11358 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11358 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11358 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11358}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sumitomo Pharma Co., Ltd. (id: 11358)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.